• 1
    Nygren KG, Andersen AN, European IVF-monitoring programme (EIM). Assisted reproductive technology in Europe, 1998. Results generated from European registers by ESHRE. European Society of Human Reproduction and Embryology. Hum Reprod 2001; 16: 245971.
  • 2
    Harlin J, Aanesen A, Csemiczky G, Wramsby H, Fried G. Delivery rates following IVF treatment, using two recombinant FSH preparations for ovarian stimulation. Hum Reprod 2002; 17: 3049.
  • 3
    Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomised study. Fertil Steril 1997; 68: 92730.
  • 4
    Ebner T, Yaman C, Moser M, Sommergruber M, Feichtinger O, Tews G. Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum Reprod 2000; 15: 42730.
  • 5
    Terriou P, Sapin C, Giorgetti C, Hans E, Spach JL, Roulier R. Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age. Fertil Steril 2001; 75: 52531.
  • 6
    Ziebe S, Loft A, Petersen JH, Andersen AG, Lindenberg S, Petersen K, Andersen AN. Embryo quality and developmental potential is compromised by age. Acta Obstet Gynecol Scand 2001; 80: 16974.
  • 7
    Tomás C, Tikkinen K, Tuomivaara L, Tapanainen JS, Martikainen H. The degree of difficulty of embryo transfer is an independent factor for predicting pregnancy. Hum Reprod 2002; 17: 26325.
  • 8
    Goswamy RK, Williams G, Steptoe PC. Decreased uterine perfusion--a cause of infertility. Hum Reprod 1988; 3: 9559.
  • 9
    Battaglia C, Artini PG, Giulini S, Salvatori M, Maxia N, Petraglia F, Volpe A. Colour Doppler changes and thromboxane production after ovarian stimulation with gonadotrophin-releasing hormone agonist. Hum Reprod 1997; 12: 247782.
  • 10
    Steer CV, Campbell S, Tan SL, Crayford T, Mills C, Mason BA, Collins WP. The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril 1992; 57: 3726.
  • 11
    Haapsamo M, Martikainen H, Räsänen J. Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ICSI: a randomized, placebo-controlled, double-blind study. Hum Reprod 2009; 24: 8616.
  • 12
    Ruopp MD, Collins TC, Whitcomb BW, Schisterman EF. Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization. Fertil Steril 2008; 90: 716.
  • 13
    Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden PR. The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod 1994; 9: 19547.
  • 14
    Rubinstein M, Marazzi A, Polak de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 1999; 71: 8259.
  • 15
    Khairy M, Banerjee K, El-Toukhy T, Coomarasamy A, Khalaf Y. Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 2007; 88: 82231.
  • 16
    Gelbaya TA, Kyrgiou M, Li TC, Stern C, Nardo LG. Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 2007; 13: 35764.
  • 17
    Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 2649.
  • 18
    McGinn T, Wyer PC, Newman TB, Keitz S, Leipzig R, Guyatt G, Evidence-Based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 2004; 171: 136973.
  • 19
    Jadad AR, Moore AR, Carrol D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 112.
  • 20
    National Collaborating Centre for Women’s and Children’s Health (UK). Fertility: Assessment and Treatment for People with Fertility Problems [Internet]. London, UK: RCOG Press, 2004.
  • 21
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 17788.
  • 22
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 55760.
  • 23
    Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323: 1015.
  • 24
    Revelli A, Dolfin E, Gennarelli G, Lantieri T, Massobrio M, Holte JG, Tur-Kaspa I. Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study. Fertil Steril 2008; 90: 168591.
  • 25
    Geva E, Amit A, Lerner-Geva L, Yaron Y, Daniel Y, Schwartz T, Azem F, Yovel I, Lessing Jb. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure andautoimmune antibodies: a prospective study. AJRI 2000; 43: 3640.
  • 26
    Qublan H, Amarin Z, Dabbas M, Farraj A-E, Beni-Merei Z, Al-Akash H, Bdoor A-n, Nawasreh M, Malkawi S, Diab F, Al-Ahmad N, Balawneh M, Abu-Salim A. Low-molecular weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil, 2008; 11: 24653.
  • 27
    Urman B, Ata B, Yakin K, Alatas C, Aksoy S, Mercan R, Balaban B. Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Hum Reprod 2009; 24: 16407.
  • 28
    Stern C, Chamley L, Norris H, Hale L, Baker HWG. A randomized, double-blind, placebocontrolled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 2003; 80: 37683.
  • 29
    Sher G, Maassarani G, Zouves C, Feinman M, Sohn S, Matzner W, Chong P, Ching W. The use of combined Heparin/Aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. AJRI 1998; 39: 2235.
  • 30
    Sher G, Zouves C, Feinman M, Maassarani G, Matzner W, Chong P, Ching W. A rationale basis for the use of combined Heparin/Aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. AJRI 1998; 39: 3914.
  • 31
    Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Chong P, Ching W. The selective use of Heparin/Aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. AJRI 1998; 40: 7482.
  • 32
    Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, Matzner W, Ching W, Chong P. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994; 9: 227883.
  • 33
    Bronson R. Immunology and reproductive medicine. Hum Reprod 1995; 10: 7557.
  • 34
    Yehia M. Luteal phase support in assisted reproduction. Debate. Middle East Fertil Soc J 2007; 12: 15860.
  • 35
    Cheung LP, Yip SK, Lok IH, Haines CJ. Aspirin and reproductive performance? Fertil Steril 1999; 72: 7545.
  • 36
    Check JH, Dietterich C, Lurie D, Nazari A, Chuong J. A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters. J Assist Reprod Genet 1998; 15: 57982.
  • 37
    Urman B, Mercan R, Alatas C, Balaban Bisiklar A, Nuhoglu A. Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. J Assist Reprod Genet 2000; 17: 58690.
  • 38
    Matassa I, Morana T, Perino A, Pane A, Castelli A, Natale E, Venezia R. Terapia con aspirina ed embryo-transfer eco guidato nella IVF-ET. Giorn It Ost Gin 2001; 3: 989.
  • 39
    Lok IH, Yip SK, Cheung LP, Leung PHY, Haines CJ. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril 2004; 81: 55661.
  • 40
    Waldenstrom U, Hellberg D, Nilsson S. Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study. Fertil Steril 2004; 81: 15604.
  • 41
    Pakkila M, Rasanen J, Heinonen S, Tinkanen H, Tuomivaara L, Makikallio K, Hippelainen M, Tapanainen JS, Martikainen H. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized,placebo-controlled double-blind study. Hum Reprod 2005; 20: 22114.
  • 42
    Duvan CI, Ozmen B, Satıroglu H, Atabekoglu CS, Berker B. Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study. J Assist Reprod Genet 2006; 23: 1521.
  • 43
    Moini A, Zafarani F, Haddadian S, Ahmadi J, Honar H, Riazi K. Effect of low-dose aspirin therapy on implantation rate in women undergoing in-vitro fertilization cycles. Saudi Med J 2007; 28: 7326.
  • 44
    Haapsamo M, Martikainen H, Rasanen J. Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. Ultrasound Obstet Gynecol 2008; 32: 68793.
  • 45
    Dirckx K, Cabri P, Merien A, Galajdova L, Gerris J, Dhont M, De Sutter P. Does low-dose aspirin improve pregnancy rate in IVF/ICSI? A randomized double-blind placebo controlled trial. Hum Reprod 2009; 24: 85660.
  • 46
    Lambers MJ, Hoozemans DA, Schats R, Homburg R, Lambalk CB, Hompes PGA. Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial. Fertil Steril 2009; 92: 9239.
  • 47
    Varnagy A, Bodis J, Manfai Z, Wilhelm F, Busznyak C, Koppan M. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. Fertil Steril 2010; 93: 22814.
  • 48
    Haapsamo M, Martikainen H, Tinkanen H, Heinonen S, Nuojua-Huttunen S, Rasanen J. Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. Hum Reprod 2010; 25: 29727.
  • 49
    Lambers MJ, Groeneveld E, Hoozemans DA, Schats R, Homburg R, Lambalk CB, Hompes PGA. Lower incidence of hypertensive complications during pregnancy in patients treated ith low-dose aspirin during in vitro fertilization and early pregnancy. Hum Reprod 2009; 24: 244750.
  • 50
    van Dooren IM, Schoot BC, Dargel E, Maas P. Low-dose aspirin demonstrates no positive effect on clinical results in the first in vitro fertilization (IVF) cycle. Fertil Steril 2004; 82(Suppl 1): S18.
  • 51
    Bordes A, Bied Damon VA, Hadj S, Nicollet B, Chomier M, Salle B. Does aspirin improve IVF results? Hum Reprod 2003; 18(Suppl 1): 119.
  • 52
    Lentini GM, Falcone P, Guidetti R, Mencaglia L. Effects of low-dose aspirin on oocyte quality, fertilization rate, implantation and pregnancy rates in unselected patients undergoing IVF. Hum Reprod 2003; 18(Suppl 1): 40.
  • 53
    Groeneveld E, Broeze KA, Lambers MJ, Haapsamo M, Dirckx K, Schoot BC, Salle B, Duvan CI, Schats R, Mol BW, Hompes PG, for the IPD MARIA study group. Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA). Hum Reprod Update 2011; 17: 5019.
  • 54
    Kontoravdis A, Makrakis E, Pantos K, Botsis D, Deligeoroglou E, Creatsas G. Proximal tubal occlusion and salpingectomy result in similar improvement in invitro fertilization outcome in patients with hydrosalpinx. Fertil Steril 2006; 86: 16429.
  • 55
    Heffner LJ. Advanced maternal age – how old is too old? N Engl J Med 2004; 351: 19279.
  • 56
    Lambers MJ, Mager E, Goutbeek J, McDonnell J, Homburg R, Schats R, Hompes PG, Lambalk CB. Factors determining early pregnancy loss in singleton and multiple implantations. Hum Reprod 2007; 22: 2759.